Back to search
FDAFDA · Food and drugs·Recall number Z-1322-2024

impression coping, repositionable, short, screw-retained, PF 4.0

Published March 27, 2024 · Recall initiated: January 24, 2024

Summary

FDA records medical device Class II recall Z-1322-2024, published March 27, 2024 and initiated January 24, 2024. Recalling firm: Thommen Medical AG; Status: Ongoing; Reported quantity: 20 units; Lot: Article No. 3.03.079; UDI/DI: 07640156475463; Lot No. 30972. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The depth of the internal canal was not manufactured according to specifications. Thus, the impression coping cannot be firmly connected to the implant.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Thommen Medical AG
Distributor
US Nationwide distribution in the states of OH and KY.
Lot
Article No. 3.03.079; UDI/DI: 07640156475463; Lot No. 30972.
Risk classification
Class II
Area (FDA)
device
Country
Switzerland

Related recalls

Questions about this recall

Was impression coping, repositionable, short, screw-retained, PF 4.0 recalled?

Yes. FDA published recall Z-1322-2024 on March 27, 2024. Reported hazard: The depth of the internal canal was not manufactured according to specifications. Thus, the impression coping cannot be firmly connected to the implant.

What should I do if I have this product?

Voluntary: Firm initiated · Letter